Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Idibell, Barcelona, Spain.
Am J Clin Nutr. 2010 Feb;91(2):381-90. doi: 10.3945/ajcn.2009.28209. Epub 2009 Dec 9.
The Mediterranean dietary pattern is believed to protect against cancer, although evidence from cohort studies that have examined particular cancer sites is limited.
We aimed to explore the association between adherence to a relative Mediterranean diet (rMED) and incident gastric adenocarcinoma (GC) within the European Prospective Investigation into Cancer and Nutrition study.
The study included 485,044 subjects (144,577 men) aged 35-70 y from 10 European countries. At recruitment, dietary and lifestyle information was collected. An 18-unit rMED score, incorporating 9 key components of the Mediterranean diet, was used to estimate rMED adherence. The association between rMED and GC with respect to anatomic location (cardia and noncardia) and histologic types (diffuse and intestinal) was investigated. A calibration study in a subsample was used to control for dietary measurement error.
After a mean follow-up of 8.9 y, 449 validated incident GC cases were identified and used in the analysis. After stratification by center and age and adjustment for recognized cancer risk factors, high compared with low rMED adherence was associated with a significant reduction in GC risk (hazard ratio: 0.67; 95% CI: 0.47, 0.94). A 1-unit increase in the rMED score was associated with a decreased risk of GC of 5% (95% CI: 0.91, 0.99). There was no evidence of heterogeneity between different anatomic locations or histologic types. The calibrated results showed similar trends (overall hazard ratio for GC: 0.93; 95% CI: 0.89, 0.99).
Greater adherence to an rMED is associated with a significant reduction in the risk of incident GC.
地中海饮食模式被认为可以预防癌症,尽管针对特定癌症部位的队列研究证据有限。
我们旨在探索欧洲前瞻性癌症与营养研究中相对地中海饮食(rMED)的依从性与胃腺癌(GC)发病之间的关系。
该研究纳入了来自 10 个欧洲国家的 485044 名(144577 名男性)年龄在 35-70 岁的参与者。在招募时,收集了饮食和生活方式信息。使用包含地中海饮食 9 个关键组成部分的 18 个单位 rMED 评分来评估 rMED 依从性。研究调查了 rMED 与 GC 在解剖部位(贲门和非贲门)和组织学类型(弥漫型和肠型)方面的关系。在亚样本中进行了校准研究以控制饮食测量误差。
平均随访 8.9 年后,确定了 449 例经证实的 GC 发病病例并用于分析。在按中心和年龄分层并调整公认的癌症风险因素后,与低 rMED 依从性相比,高 rMED 依从性与 GC 风险显著降低相关(风险比:0.67;95%CI:0.47,0.94)。rMED 评分每增加 1 分,GC 风险降低 5%(95%CI:0.91,0.99)。不同解剖部位或组织学类型之间没有证据表明存在异质性。校准结果显示出相似的趋势(GC 的总风险比:0.93;95%CI:0.89,0.99)。
较高的 rMED 依从性与 GC 发病风险的显著降低相关。